Enrich Therapeutics

About:

Enrich Therapeutics is a biotechnology startup.

Top Investors: Connecticut Innovations, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Boston Harbor Angels

Description:

Enrich Therapeutics is a biotechnology startup focused on the development of novel single-cell isolation platform along with the critical life science applications.

Total Funding Amount:

$2.02M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Worcester, Massachusetts, United States

Founded Date:

2018-07-01

Contact Email:

inquiry(AT)enrichtx.com

Founders:

Qi Zhao

Number of Employees:

1-10

Last Funding Date:

2020-08-21

IPO Status:

Private

Industries: